CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Contraception - Management
For how long can a levonorgestrel-releasing intrauterine system (IUS) be left in place?
- The levonorgestrel-releasing intrauterine system (IUS) may be left in place for up to 5 years.
- However, women who are aged 45 or more years at the time of IUS insertion may retain the device until they no longer require contraception, even if this is beyond the duration of the UK Marketing Authorisation.
Clarification / Additional information
- Use of the levonorgestrel-releasing intrauterine system after the age of 45 years:
- Advise about the decline of fertility with age, the risks associated with IUS insertion (infection, perforation, expulsion), and potential loss of contraceptive efficacy if used beyond the recommended life of the device.
- Offer the choice to continue with the IUS, replace the IUS, and/or use an alternative method.
- Informed consent is needed when using outside the licensed indications, and should be documented in the notes.
Basis for recommendation
© NHS Institute for Innovation and Improvement